Term ends Jun 8, 2036 · High confidence
20-year base term ends Jan 23, 2035
Held by Novartis AG
Filed Jul 10, 2020 as application 16/925,980 · Granted Nov 28, 2023
Base term plus 502 days of patent term adjustment (USPTO delay)
Today
2015
2036
Clock starts
Jan 23, 2015
Jan 23, 2015
Term ends
Jun 8, 2036
Jun 8, 2036
Granted
Nov 28, 2023
Nov 28, 2023
base term
patent term adjustment
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
502
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 502 days past its 20-year base term on prosecution delay. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 23, 2015, when application 14/604,415, the earliest non-provisional in its chain, was filed (this one was filed Jul 10, 2020) | Jan 23, 2035 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +502 days, USPTO patent term adjustment record | Jun 8, 2036 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jun 8, 2036 | High confidence |
This family
| US 9,683,048 | In force Jan 2035 | Jan 2035 |
| US 9,815,898 | In force Jan 2035 | Jan 2035 |
| US 10,752,687 | In force Aug 2035 | Aug 2035 |
| US 11,827,704 | this patent Jun 2036 | Jun 2036 |
| Application 18/489,578 | Abandoned not computed | not computed |
| Application 18/680,465 | Pending not computed | not computed |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 6, 2020 Reel 53988, frame 537 | Freeman, Gordon James | Dana-Farber Cancer Institute, Inc. | Assignment of Assignor's Interest |
| Oct 6, 2020 Reel 53988, frame 710 | Sharpe, Arlene Helen | President and Fellows of Harvard College | Assignment of Assignor's Interest |
| Oct 6, 2020 Reel 53988, frame 776 | Chang, Hwai Wen; Frey, Gerhard Johann | BioAtla, LLC | Assignment of Assignor's Interest |
| Oct 6, 2020 Reel 53988, frame 916 | BioAtla, LLC | Costim Pharmaceuticals Inc. | Assignment of Assignor's Interest |
| Oct 6, 2020 Reel 53988, frame 990 | Blattler, Walter A.; Mataraza, Jennifer Marie; Sabatos-peyton, Catherine Anne | Costim Pharmaceuticals Inc. | Assignment of Assignor's Interest |
| Oct 6, 2020 Reel 53989, frame 99 | Costim Pharmaceuticals Inc. | Novartis AG | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jun 2036
Term ends Jun 8, 2036. Maintenance fees still fall due before then
Note
The 502 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
7
later US patents cite this one
That is top 10% of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.